Cantor Fitzgerald raises Merck target price to $145
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Delivery soared by 85% but failed to prevent the death cross; Rivian (RIVN.US) dilution risk sparks panic
Despite the R2 model driving an 85% year-on-year increase in deliveries, Rivian's stock price continues to decline due to technical death cross, high short interest, and risks of equity dilution, facing a severe market test.
Barry warns Fannie Mae (FNMA.US) has peaked: Technical patterns suggest the rebound is ending
Michael Burry pointed out that Fannie Mae and Freddie Mac stocks have formed a head and shoulders top pattern and believes they are now worthless. He warned that the conversion of Treasury preferred shares will dilute shareholder equity, and that the market rebound has narrowed to levels last seen in 2000.
JPMorgan lowers General Motors’ target price to $110
CommBank says September wage growth slows, easing risk of wage-driven inflation
Crypto prices
More
